Yoshikawa Tomoki, Fujii Hikaru, Okutani Akiko, Shibamura Miho, Omura Natsumi, Egawa Kazutaka, Kato Hirofumi, Inagaki Takuya, Harada Shizuko, Yamada Souichi, Morikawa Shigeru, Saijo Masayuki
Department of Virology 1, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan.
Department of Veterinary Science, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan.
PLoS One. 2018 Feb 23;13(2):e0192725. doi: 10.1371/journal.pone.0192725. eCollection 2018.
LC16m8 (m8), a highly attenuated vaccinia virus (VAC) strain, was developed as a smallpox vaccine, and its safety and immunogenicity have been confirmed. Here, we aimed to develop a system that recovers infectious m8 from a bacterial artificial chromosome (BAC) that retains the full-length viral genomic DNA (m8-BAC system). The infectious virus was successfully recovered from a VAC-BAC plasmid, named pLC16m8-BAC. Furthermore, the bacterial replicon-free virus was generated by intramolecular homologous recombination and was successfully recovered from a modified VAC-BAC plasmid, named pLC16m8.8S-BAC. Also, the growth of the recovered virus was indistinguishable from that of authentic m8. The full genome sequence of the plasmid, which harbors identical inverted terminal repeats (ITR) to that of authentic m8, was determined by long-read next-generation sequencing (NGS). The ITR contains x 18 to 32 of the 70 and x 30 to 45 of 54 base pair tandem repeats, and the number of tandem repeats was different between the ITR left and right. Since the virus recovered from pLC16m8.8S-BAC was expected to retain the identical viral genome to that of m8, including the ITR, a reference-based alignment following a short-read NGS was performed to validate the sequence of the recovered virus. Based on the pattern of coverage depth in the ITR, no remarkable differences were observed between the virus and m8, and the other region was confirmed to be identical as well. In summary, this new system can recover the virus, which is geno- and phenotypically indistinguishable from authentic m8.
LC16m8(m8)是一种高度减毒的痘苗病毒(VAC)株,被开发用作天花疫苗,其安全性和免疫原性已得到证实。在此,我们旨在开发一种从保留全长病毒基因组DNA的细菌人工染色体(BAC)中恢复感染性m8的系统(m8-BAC系统)。从名为pLC16m8-BAC的VAC-BAC质粒中成功恢复了感染性病毒。此外,通过分子内同源重组产生了不含细菌复制子的病毒,并从名为pLC16m8.8S-BAC的改良VAC-BAC质粒中成功恢复。而且,所恢复病毒的生长与正宗m8的生长没有区别。通过长读长下一代测序(NGS)确定了该质粒的全基因组序列,该质粒具有与正宗m8相同的反向末端重复序列(ITR)。ITR包含70个碱基对串联重复序列中的18至32个以及54个碱基对串联重复序列中的30至45个,并且ITR左右两侧的串联重复序列数量不同。由于预期从pLC16m8.8S-BAC中恢复的病毒将保留与m8相同的病毒基因组,包括ITR,因此进行了短读长NGS后的基于参考的比对以验证所恢复病毒的序列。基于ITR中的覆盖深度模式,在所恢复病毒与m8之间未观察到明显差异,并且其他区域也被证实是相同的。总之,这个新系统可以恢复在基因型和表型上与正宗m8无法区分的病毒。